Loading
companiesCompany
COTA
Curated oncology real-world data with clinically abstracted endpoints, used in FDA-recognised RWE studies.
Overview
COTA, based in New York, provides curated oncology real-world data with clinically abstracted endpoints, used in FDA-recognised real-world evidence studies. Its data come from academic and community sites, it developed a nodal analysis method, and it emphasises regulatory-grade abstraction of outcomes from records. OnCo links it to oncology EHR and real-world data platforms. Whether manually abstracted endpoints can be produced at the scale and cost that make real-world evidence routine is the open question. The real-world data platform page carries the wider debate.
Similar pages
- CompanyConcertAI
Shares Oncology EHR and real-world data platforms and the tag supporting.
- CompanyDatavant
Shares Oncology EHR and real-world data platforms and the tag supporting.
- CompanyKomodo Health
Shares Oncology EHR and real-world data platforms and the tag supporting.
- CompanyEpic Systems
Shares Oncology EHR and real-world data platforms and the tag supporting.
- CompanyTriNetX
Shares Oncology EHR and real-world data platforms and the tag supporting.
- CompanyIQVIA
Shares Oncology EHR and real-world data platforms and the tag supporting.
- CompanyMcKesson / The US Oncology Network
Shares Oncology EHR and real-world data platforms and the tag supporting.
- TechnologyFederated learning and privacy-preserving AI
Shares Oncology EHR and real-world data platforms and the tag supporting.